Researchers at Children's Hospital of Philadelphia (CHOP) reported long-term clinical outcomes for the largest single center cohort of individuals who underwent complex reconstructive surgery for ...

Longeveron Inc. has completed enrollment for its Phase 2b clinical trial, ELPIS II, which is testing laromestrocel, a cellular therapy aimed at improving outcomes in infants with Hypoplastic Left ...

For decades, it was impossible for clinicians to know which babies with major heart defects might eventually have developmental abnormalities, like ADHD and learning differences. Now, by adapting a ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...